FDA Inspection
Zhejiang Huahai Pharmaceutical Co., Ltd.Zhejiang Huahai Pharmaceutical Co., Ltd. – FDA Inspection, Jun 28, 2019
Record Details
This FDA Inspection record concerns Zhejiang Huahai Pharmaceutical Co., Ltd., with an inspection on June 28, 2019, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · df4d4247-aa87-49a8-a139-e03b3c32f929
Inspection Facts
- Inspection number
- 1094941
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Zhejiang Huahai Pharmaceutical Co., Ltd.
10| Date | Classification | Office | Project area |
|---|---|---|---|
| April 24, 2026 | Not classified | Office of Inspections and Investigations | |
| January 24, 2025 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 2, 2021 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 31, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 26, 2018 | Not classified | Office of Inspections and Investigations |
Other documents for Zhejiang Huahai Pharmaceutical Co., Ltd.
- FDA Inspection 1319736 - 2026-04-24
- FDA Inspection 1259818 - 2025-01-24
- FDA Inspection 1149252 - 2021-07-02
- FDA Inspection 1093250 - 2019-05-31
- FDA Inspection 1042575 - 2018-01-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.